13 February 2024
Iconic Labs PLC
("Iconic" or the "Company")
Result of AGM
Iconic Labs PLC (LSE: ICON) is pleased to announce that at the Company's Annual General Meeting ('AGM') held earlier today, Resolutions 1 to 10 were all duly approved by shareholders by way of a poll.
At the meeting, inter alia, a resolution was passed which approved the sub-division and conversion of each existing ordinary share of £0.10 ("Existing Ordinary Shares") into one new ordinary share of £0.0001 (a "New Ordinary Share") and one deferred share of £0.0999 (a "Deferred Share") (each such Deferred Share having no voting or dividend rights and effectively being worthless) in order that the nominal value of a New Ordinary Share is less than the price of a share in the market.
As a result, the Company's issued share capital will consist of 11,161,483 ordinary shares of £0.0001 each with one voting right (and deferred shares of £0.0999 each with limited rights and which will not be admitted to trading). Admission in respect of such New Ordinary Shares will become effective and that dealings in those New Ordinary Shares will commence on 14 February 2024.
The above figure of 11,161,483 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
The results of the poll were as follows:
|
|
Resolutions |
For |
% |
Against |
% |
Withheld |
|
1 |
To receive and adopt the accounts for the financial year ended 30 June 2023. |
3,374,840 |
99.19 |
27,718 |
0.81 |
4,837 |
|
2 |
To re-appoint RPG Chartered Accountants as Auditors. |
3,369,888 |
99.17 |
28,070 |
0.83 |
9,437 |
|
3 |
To authorise the Directors to determine the remuneration of the Auditors. |
3,369,670 |
99.03 |
32,888 |
0.97
|
4,837 |
|
4 |
To re-appoint Bradley Tyler Taylor as a Director. |
3,205,262 |
94.20 |
197,226 |
5.80 |
4,907 |
|
5 |
To re-appoint Bela Lendvai-Lintner as a Director. |
3,206,467 |
94.24 |
196,021 |
5.76 |
4,907 |
|
6 |
To re-appoint Victor Humberdot as a Director. |
3,206,467 |
94.24 |
196,021 |
5.76 |
4,907 |
|
7 |
To authorise the Directors to allot shares up to a maximum aggregate nominal amount of £4,668,047.83. |
3,193,245 |
94.06 |
201,631 |
5.94 |
12,519 |
|
|
Special Resolutions: |
|
|
|
|
|
|
8 |
To empower the Directors to generally allot relevant equity securities. |
3,193,597 |
94.07 |
201,279 |
5.93 |
12,519 |
|
9 |
Issued ordinary share capital be sub-divided and converted into one New Ordinary Share of £0.0001 and one Deferred Share of £0.0999. |
3,192,372 |
93.91 |
207,104 |
6.10 |
7,919 |
|
10 |
To authorise the Directors to make market purchases of own shares. |
3,371,803 |
99.19 |
27,673 |
0.81 |
7,919 |
- Ends -
For more information, please contact:
|
Iconic Labs
Brad Taylor, Chief Executive Officer |
Tel: +44 (0) 7462 156238 |
|
Novum Securities Limited David Coffman / Daniel Harris |
Tel: +44 (0) 20 7399 9400
|
|
Yellow Jersey PR Sarah Hollins Annabelle Wills Bessie Elliot
|
Tel: +44 (0) 20 3004 9512 iconic@yellowjerseypr.com
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
